CHU (University Hospital Center) de Poitiers, France, has chosen Sweden-based medical technology firm Elekta as the main partner in an ambitious programme to improve radiation therapy treatment capacity in the Poitou-Charente region.
The hospital recently assigned Elekta to deliver three Elekta Synergy digital linear accelerator systems for intensity modulated and image-guided radiation therapy, to replace existing equipment. The order is valued at approximately €5 million.
Intensity modulated and image-guided radiation therapy (IMRT & IGRT) has during the last couple of years become standard for new deliveries of radiation therapy solutions.
CHU de Poitiers, the only radiotherapy centre focusing on advanced radiation therapy in the Poitiers area has chosen to upgrade their facilities with three Elekta Synergy systems.
“Radiation therapy is one of the most important weapons in the arsenal to fight cancer”, comments Mr Jean-Pierre Dewitte, CEO of Poitiers University Hospital.
“Integrated 3D imaging, which is what is needed for true image-guided treatment, will most certainly be one key factor for future improved outcomes,” he added.
The system will enable radiation oncology staff to use extremely precise and accurate technique close to critical structures, while at the same time being flexible enough to handle virtually all cases presented in a radiation therapy department.
Vincent Beilvert, Managing Director, Elekta France, commented:
“We are very pleased to partner with CHU de Poitiers in the effort to improve cancer care and we are looking forward to working with Mr Dewitte and the radiation therapy department at CHU Poitiers to explore advanced methods such as in-Vivo dosimetry, gating and VMAT (Volumetric Intensity Modulated Radiation Therapy).”